-The Hindu Pollution standards exist only for ambient air quality and not for individual power plants, says report Emissions from coal-fired power plants is taking a heavy toll on human life across large parts of India. In 2011-2012, a first-of-its-kind study in the country estimates it resulted in a whopping 80,000 to 1,15,000 premature deaths and more than 20 million asthma cases from exposure to a total PM10 (particulate matter) pollution. Titled ‘Coal...

-The Hindu Communist Party of India (Marxist) Polit Bureau member Brinda Karat on Wednesday demanded an independent inquiry into the Comptroller and Auditor General (CAG) report, which has pointed out serious lapses and wrongdoings in the Rs. 52,000-crore farm debt waiver scheme. Ms. Karat was talking to journalists at the party office here, before resuming her programme of “Sangharsh Sandesh Jatha,” which began from Jallianwala Bagh in Amritsar on March 4. She said...

-The Times of India As many as 436 people died last year due to serious adverse events (SAE) during clinical trials. Investigations are now on to ascertain how many of the deaths were caused by drugs administered to the trial subjects. Union health minister Ghulam Nabi Azad said on Friday that deaths could be due to life-threatening diseases such as cancer, heart failure and stroke or side-effects of the drugs or their...

-The Economic Times Beginning today, the country's highest court will hear petitions filed by telecom-industry lobbies challenging a recent Rajasthan High Court order that directed telecom companies to remove cellphone towers from schools, hospitals, jails and heritage buildings in the state amid claims that tower radiation was harmful. Officials of two leading industry associations, representing mobile operators and telecom tower companies, feel the Supreme Court's verdict in the case could set...

-The Economic Times Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive legal action against local generic players to protect the market of patented drugs and delay the entry of low cost generic medicines in the 60,000-crore domestic drug market. MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few months' window between the...